Real Chemistry Executive and Leadership Team

Jeffrey Lupinacci, the Chief Financial Officer at Real Chemistry, manages the company's financial operations and strategic fiscal planning. Lupinacci oversees all aspects of financial reporting, budgeting, forecasting, and capital management, ensuring the company's financial health and stability. This critical role involves analyzing financial performance, identifying cost-saving opportunities, and guiding investment strategies to support Real Chemistry's growth objectives. The Chief Financial Officer works closely with executive leadership to align financial decisions with the company's overarching mission of driving commercial success in healthcare through AI-powered experiences. Jeffrey Lupinacci's expertise is vital in navigating the complex financial landscape of the healthcare industry. By maintaining rigorous financial discipline, Lupinacci enables sustained innovation and market leadership.

Jj Schmuckler, the Group President and Chief Revenue Officer at Real Chemistry, drives revenue growth and client relationship management across key business segments. Schmuckler leads the sales organization, focusing on expanding market share and ensuring client success by delivering AI-powered healthcare experiences. This executive role involves developing and executing strategies to achieve ambitious revenue targets and foster long-term partnerships. The Chief Revenue Officer works collaboratively with other leaders to align commercial efforts with the company's innovative service offerings. Jj Schmuckler's leadership ensures that Real Chemistry consistently meets and exceeds client expectations, reinforcing its position as a trusted partner in healthcare commercialization. Schmuckler's strategic oversight is fundamental to the company's sustained financial performance and market expansion.

Elyse Margolis, the Group President At Real Chemistry, oversees significant client portfolios and drives strategic initiatives for key accounts. Margolis focuses on deepening client engagement and ensuring the successful implementation of AI-powered healthcare experiences that align with customer objectives. This leadership position involves fostering strong relationships with healthcare organizations, understanding their unique challenges, and delivering tailored solutions. The Group President works cross-functionally to integrate various service offerings, maximizing client value and driving business outcomes. Elyse Margolis's dedication to client success is central to Real Chemistry's mission of commercializing healthcare innovations. Margolis ensures that client strategies are robust and effectively executed, contributing to sustained growth and market impact.

Shoreen Maghame, the President & Communications & Corporate Strategy Executive at Real Chemistry, directs the company's strategic communications and corporate planning efforts. Maghame is responsible for shaping the company's public image, managing internal and external communications, and developing long-term strategic roadmaps. This executive function involves aligning corporate messaging with business objectives and ensuring consistent brand representation across all platforms. The President & Communications & Corporate Strategy Executive collaborates closely with leadership to identify growth opportunities and navigate market dynamics. Shoreen Maghame's strategic insights are crucial for positioning Real Chemistry as a leader in AI-driven healthcare experiences. Maghame's oversight ensures that strategic initiatives are well-defined and effectively communicated to stakeholders.

Cali Howitt, the President, Medical Communications (US) at Real Chemistry, leads the company's medical communications division within the United States. Howitt directs the strategy and execution of medical affairs initiatives, ensuring scientific accuracy and compliance in all communications. This role involves managing teams of medical experts and communication specialists to deliver impactful scientific content and engagement strategies for healthcare clients. The President, Medical Communications (US) works to enhance the understanding and adoption of innovative healthcare solutions through clear, evidence-based communication. Cali Howitt's leadership ensures that Real Chemistry's medical communication services effectively support client objectives and contribute to improved patient outcomes. Howitt's focus is on driving excellence in scientific engagement across the US market.

Kath Harrison, the Group President, International Growth at Real Chemistry, spearheads the company's expansion into global markets. Harrison develops and implements strategies to establish Real Chemistry's presence and drive revenue in key international regions. This leadership role involves identifying new market opportunities, building local partnerships, and adapting the company's AI-powered healthcare solutions to diverse cultural and regulatory environments. The Group President, International Growth works closely with regional teams to ensure cohesive execution of global business objectives. Kath Harrison's vision is instrumental in extending Real Chemistry's impact beyond domestic borders. Harrison's efforts are focused on cultivating sustainable growth and establishing the company as a global leader in healthcare innovation.

Mary Duch, the Group President, Integrated Communications at Real Chemistry, leads the company's comprehensive communication strategies. Duch oversees the development and deployment of multi-channel communication plans that integrate various aspects of marketing, public relations, and digital engagement for healthcare clients. This executive function focuses on creating cohesive and impactful narratives that resonate with target audiences and drive desired actions. The Group President, Integrated Communications collaborates with cross-functional teams to ensure seamless execution and maximum reach for client campaigns. Mary Duch's expertise is critical in leveraging integrated approaches to enhance brand visibility and achieve strategic communication goals. Duch's leadership ensures that all communication efforts are aligned and contribute to the overall success of Real Chemistry's clients.

Brandon Pletsch, the President, Scientific Visualization at Real Chemistry, directs the company's specialized services in scientific visualization. Pletsch leads the team responsible for creating compelling visual representations of complex scientific data and concepts for healthcare and life sciences clients. This role involves leveraging advanced technology and creative expertise to enhance understanding and communication of scientific information. The President, Scientific Visualization works to ensure that visualizations are accurate, engaging, and effectively support client objectives, such as drug development, patient education, and regulatory submissions. Brandon Pletsch's leadership drives innovation in how scientific information is presented and consumed. Pletsch's focus is on delivering high-quality visual solutions that advance scientific communication and commercial success.

Andrew Johnson, the Chief Information Officer at Real Chemistry, directs the company's technology infrastructure and digital strategy. Johnson oversees the development and implementation of all IT systems, ensuring robust cybersecurity measures and data integrity across the organization. This leadership role involves architecting scalable technology solutions that support Real Chemistry's AI-powered platforms and enhance operational efficiency. By managing the technological backbone, Johnson enables the seamless delivery of innovative healthcare experiences to clients. The Chief Information Officer's focus remains on leveraging cutting-edge technology to drive business objectives and maintain a competitive edge in the evolving healthcare landscape. Andrew Johnson ensures that technology investments directly align with the company's mission to create customer-centric healthcare solutions.

Ericka McKenna, the Chief Marketing Officer at Real Chemistry, spearheads all marketing initiatives and brand strategy. McKenna directs the creation and execution of integrated campaigns designed to elevate Real Chemistry's market presence and attract new clients within the healthcare sector. This role involves deep collaboration with sales and product development teams to ensure marketing efforts resonate with target audiences and highlight the company's AI-driven solutions. The Chief Marketing Officer is responsible for market analysis, competitive intelligence, and identifying emerging opportunities to drive growth. By shaping the company's narrative, Ericka McKenna ensures that Real Chemistry's commitment to customer-centric healthcare experiences is clearly communicated. McKenna's strategic vision guides the company's outreach, reinforcing its position as a leader in healthcare innovation.